$BOLT SEC Filings

Filed On	Filing
23 Oct 2026	8-K: Entry into a Material Definitive Agreement; Termination of a Material Definitive Agreement +6 more PRINCE MERGER SUB II, LLC, a Delaware limited liability company;
06 Oct 2026	8-K: Entry into a Material Definitive Agreement On October 1, 2026, Bolt Biotherapeutics, Inc. (the “Company”) entered into the Second Amendment to Lease (the “Second Lease Amendment”) with HCP LS Redwood City LLC, as landlord (the “Landlord”). The Second Lease Amendment amends that c...
21 Sep 2026	Form 4: Yonehiro Grant, Chief Operating Officer Sold 1,417 shares ($5.35K) · Sold 4,909 shares ($16.3K) · Sold 6,850 shares ($22.2K)
21 Sep 2026	Form 4: Nemec Sarah, Senior VP, Finance and PAO Bought 509 shares ($1.97K) · Sold 843 shares ($3.18K) · Sold 2,922 shares ($9.7K) · 1 more
21 Sep 2026	Form 4: Quinn William P., Director Bought 637 shares ($2.47K) · Sold 1,889 shares ($7.13K) · Sold 6,545 shares ($21.7K) · 1 more
13 Aug 2026	SCHEDULE 13G
11 Aug 2026	10-Q
11 Aug 2026	8-K: Results of Operations and Financial Condition
11 Jun 2026	Form 4: Berner Laura, Director Granted 5,000 Stock Option (Right to Buy)
11 Jun 2026	Form 4: Laporte Kathleen, Director Granted 5,000 Stock Option (Right to Buy)
11 Jun 2026	Form 4: Dupont Jakob, Director Granted 5,000 Stock Option (Right to Buy)
11 Jun 2026	Form 4: O'callaghan Brian, Director Granted 5,000 Stock Option (Right to Buy)
11 Jun 2026	Form 4: Onetto Nicole, Director Granted 5,000 Stock Option (Right to Buy)
11 Jun 2026	8-K: Submission of Matters to a Vote of Security Holders
12 May 2026	10-Q
12 May 2026	8-K: Results of Operations and Financial Condition
28 Apr 2026	ARS
28 Apr 2026	DEFA14A
28 Apr 2026	DEF 14A
12 Mar 2026	S-8

Comments